Compare LMRI & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMRI | AHCO |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | 4335 | N/A |
| Industry | Medical Specialities | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | 2017 |
| Metric | LMRI | AHCO |
|---|---|---|
| Price | $11.02 | $10.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $20.75 | $13.50 |
| AVG Volume (30 Days) | 571.0K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,244,857,000.00 |
| Revenue This Year | $6.35 | $9.00 |
| Revenue Next Year | $5.61 | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.45 | $8.51 |
| 52 Week High | $19.45 | $13.43 |
| Indicator | LMRI | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 55.80 |
| Support Level | $10.21 | $10.80 |
| Resistance Level | $12.93 | $12.87 |
| Average True Range (ATR) | 0.74 | 0.40 |
| MACD | -0.18 | 0.05 |
| Stochastic Oscillator | 30.24 | 55.61 |
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.